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Godelieve Conings6, Johan Flamaing3,7, Jean-Pierre Lobelle8, Hans Wildiers2,9 and Koen Milisen3,4*Abstract
Background: In the older population falls are a common problem and a major cause of morbidity, mortality and
functional decline. The etiology is often multifactorial making the identification of fall predictors essential for
preventive measures. Despite this knowledge, data on falls within the older cancer population are limited. The
objective of this study was to evaluate the occurrence of falls within 2 to 3 months after cancer treatment decision
and to identify predictors of falls (≥1 fall) during follow-up.
Methods: Older patients (70 years or more) with a cancer treatment decision were included. At baseline, all
patients underwent geriatric screening (G8 and Flemish Triage Risk Screening Tool), followed by a geriatric
assessment including living situation, activities of daily living (ADL), instrumental activities of daily living (IADL),
fall history in the past 12 months, fatigue, cognition, depression, nutrition, comorbidities and polypharmacy.
Questionnaires were used to collect follow-up (2–3 months) data. Univariate and multivariate analyses were
performed to identify predictors for falls (≥1 fall) during follow-up.
Results: At baseline, 295 (31.5%) of 937 included patients reported at least one fall in the past 12 months with 88
patients (29.5%) sustaining a major injury. During follow-up (2–3 months), 142 (17.6%) patients fell, of whom 51.4%
fell recurrently and 17.6% reported a major injury. Baseline fall history in the past 12 months (OR = 3.926), fatigue
(OR = 0.380), ADL dependency (OR = 0.492), geriatric risk profile by G8 (OR = 0.471) and living alone (OR = 1.631)
were independent predictors of falls (≥1 fall) within 2–3 months after cancer treatment decision.
Conclusion: Falls are a serious problem among older cancer patients. Geriatric screening and assessment data can
identify patients at risk for a fall. A patient with risk factors associated with falls should undergo further evaluation
and intervention to prevent potentially injurious fall incidents.
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Falls are a common problem in the older population.
One third of individuals 65 years and older fall at least
once a year and up to half of these patients have recurrent
falls [1,2]. Fortunately, most falls do not result in any
serious harm. Five to 10% of falls lead to a fracture, head
injury or serious soft tissue injury [3,4]. Additionally, acci-
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unless otherwise stated.and falls account for two thirds of these deaths due to
unintentional injuries [3]. Further, the fear of a (new) fall
often leads to disability. In brief, falls represent a major
cause of morbidity, mortality and functional decline as
well as dependency including premature nursing home
admissions [1,3].
The etiology of a fall is often multifactorial due to a
combination of physiological age-related changes, patho-
logical elements and behavioral and environmental factors
[5,6]. Therefore, identification of strong fall predictors is
essential in the planning of preventive measures. Several
epidemiologic studies in very heterogeneous, older popu-
lations have identified fall history as a main risk factor.
Use of sedative medications, gait problems, depression,ntral. This is an Open Access article distributed under the terms of the Creative
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determinants of falls [6,7]. However, the effectiveness of
fall screening tools based on these results remains unclear
[8]. For that reason, further research in subpopulations is
warranted. The data on falls in older cancer patients are
limited, stating merely the presence or absence of falls ra-
ther than risk factors [9]. Seventeen of 91 newly diagnosed
older cancer patients experienced at least one fall in the
past 6 months following diagnosis in a study by Puts
et al. [10]. Stone et al. reported that 50% of 185 adults
with advanced cancer fell during a 6-month follow-up
[11]. Hitcho et al. (2004) described that 74% of first
falls among oncology inpatients resulted in an injury
[12]. These preliminary results point to a high inci-
dence of falls and a higher complication rate in older
cancer patients compared to the data in the general
population of older adults. However, they must be
interpreted with caution because of the small sample
sizes and high dropout rates.
The objective of this study was to evaluate the occurrence
of falls among older cancer patients within 2 to 3 months
after cancer treatment decision and to identify predictors
for falls (≥1 fall) during follow-up.
Methods
The methodology used in the current study has been
described in detail elsewhere [13]. A brief summary is
given below.Figure 1 Flow-chart of patient selection.Study design and population
This prospective, observational cohort study was per-
formed in two academic hospitals in Belgium from
October 2009 till July 2011. Patients aged 70 years and
older, in whom a cancer treatment decision had to be
made due to new diagnosis or disease progression/relapse,
were approached by a trained nurse during a hospital visit.
Depending on the time point of assessment - new diagno-
sis or disease progression/relapse – the treatment decision
is a first decision or a subsequent decision and includes all
different kinds of cancer treatment. Six tumor types were
included: breast, colorectal, ovarian, lung, prostate cancer
and hematological malignancies. The study was approved
by the Ethical Committee of both participating hospitals
(University Hospitals Leuven and University Hospital
Brussels) and written informed consent (IC) was obtained
by all patients or their caregiver.
Baseline geriatric screening and assessment
The presence of a geriatric risk profile was assessed in all
patients by a trained nurse using the G8 (≤14 is abnormal)
and by the Flemish version of the Triage Risk Screening
Tool (fTRST) (≥1 is abnormal) [13-16].
At baseline, a geriatric assessment (GA) was performed
in all patients. This GA was based on the Geriatric
Minimum Data Set of Clinical Trials [17] and comprised
demographic and social data such as age, gender and
living situation. Functional status was evaluated using
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and Instrumental Activities of Daily Living (IADL) (<5
(male)/8(female) is abnormal) [19], as well as fall history
by asking the number of falls and fall-related injuries in
the past 12 months, respectively.
A fall was defined as ‘an unexpected event in which
the older person comes to rest on the ground, floor or
lower level’ [20,21]. Injuries were divided in two groups:
minor and major. Minor injuries were defined as scrapes
and scratches, bruises, superficial wounds that needed
no or minimal medical attention. Major injuries were
defined as sprains, severe soft-tissue bruises, severe head
injuries, joint distortions and dislocations, contusions,
lacerations, loss of consciousness, and fractures [22].
Cognition was evaluated using the Mini Mental State
Examination (MMSE) (<24 is abnormal) [23] and risk
for depression by the 15-item Geriatric Depression Scale
(GDS-15) (≥5 is abnormal) [24]. Nutritional status was
assessed using the Mini Nutritional Assessment-Short
Form (MNA-SF) (≤11 is abnormal) [25,26]. The CharlsonTable 1 Patient and clinical characteristics*
Age, years (median (range) (n = 937)
Gender (n = 937) - Female
- Male
Tumor type (n = 937) - Carcinoma
- Hematological malignancies
Timepoint of assessment (n = 937) - New diagnosis
- Disease progression/relapse
Carcinoma (n = 788) - Stage
Hematological malignancies (n = 149) - Setting
Comorbidities CCI (0–37) (n = 937)
Pain VAS (0–10) (n = 936)
Performance status ECOG-PS (0–5) (n = 936)
Polypharmacy (n = 910)
Legend: CCI: Charlson Comorbidity Index; VAS: Visual Analogue Scale; ECOG-PS: Eas
*Table adapted from Kenis et al., 2014 [13].Comorbidity Index (CCI) (≥1 is abnormal) [27] was used
to describe the comorbidities. Self-perceived fatigue was
assessed using the Mobility-Tiredness Test (Mob-T) [28]
and pain was evaluated with the Visual Analogue Scale
(VAS) (≥1 is abnormal) [29]. Classical oncological parame-
ters such as Eastern Cooperative Oncology Group -
Performance Status (ECOG-PS) [30], tumor characteristics
(type and stage) and treatment details were recorded. The
number of drugs (www.bcfi.be) taken during the week
before inclusion was recorded to detect polypharmacy
(≥5 different drugs).
Follow-up
Occurrence of falls and fall-related injuries was registered
during two to three months after cancer treatment deci-
sion. A questionnaire was sent to the patient at home, ask-
ing to self-report the variables of interest. Patients were
contacted by telephone or in person in the hospital in case
the questionnaire was not returned, in order to complete
the follow-up data.76 (70 – 95)
n % 95% CI
595 63.5 60.4-66.6
342 36.5 33.4-39.6
- Breast 379 40.4 37.3-43.6
- Colorectal 193 20.6 18.0-23.2
- Lung 73 7.8 6.1-9.5
- Ovarian 59 6.3 4.7-7.9




- I-III 380 48.2 44.7-51.7
- IV 408 51.8 48.2-55.3
- Curative 48 32.2 24.7-39.7
- Palliative 101 67.8 60.3-75.3
- No comorbidities: score 0 432 46.1 42.9-49.3
- Comorbidity score 1 232 24.8 22.0-27.5
- Comorbidity score≥ 2 273 29.1 26.2-32.0
- No pain: score 0 467 49.9 46.7-53.1
- Mild pain: score 1 – 3 144 15.4 13.1-17.7
- Pain to treat: score≥ 4 325 34.7 31.7-37.8
- Score 0-1 677 72.3 69.5-75.2
- Score 2-4 259 27.7 27.3-33.1
- 0-4 different drugs 427 46.9 43.7-50.2
- ≥5 different drugs 483 53.1 49.8-56.3
tern Cooperative Oncology Group – Performance Status.
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Data analyses were performed using SAS v.9.3. Descrip-
tive statistics were performed to characterize the total
study population.
For comparative analyses, different groups were defined:
non-fallers (no falls), fallers (≥1 fall), single fallers (=1 fall)
and recurrent fallers (≥2 falls). Comparisons between
groups for continuous data were done with Students’ t
test, Wilcoxon test, analysis of variance or use of gen-
eral linear model, as appropriate. Once significance
was achieved between 2 groups, further analysis was
conducted with the Tukey method. Categorical data
were compared and tested with chi-square test and/or
Fisher’s exact test with or without the Monte Carlo
method, as appropriate. Following potential markers of
falling during follow-up were analyzed at univariate
level: age, gender, ECOG-PS, fTRST, G8, ADL, IADL,Table 2 Results of the geriatric screening and GAa
Screening Cut-off Score
fTRST (0–6) ≥1 - Absen
- Presen
G8 (0–17) ≤14 - Absen
- Presen
GA Item/Instrument Score
Living situation (n = 937) - Living
- Not li
Functional status ADL (6–24) (n = 937) - Indep
- Depen
IADL (0-5/8) (n = 937) - Indep
- Depen





Fatigue MOB-T (0–6) (n = 937) - No fa
- Presen
Cognitionc MMSE (0–30) (n = 936) - Norm
- Mild c
- Severe
Depression GDS-15 (0–15) (n = 933) - Not a
- At risk
Nutritiond MNA-SF (0–14) (n = 937) - Norm
- Risk o
- Malno
Legend: fTRST: Flemish version of the Triage Risk Screening Tool; GA: Geriatric Asse
Living; MOB-T: Mobility – Tiredness Test; MMSE: Mini Mental State Examination; GD
aTable adapted from Kenis et al., 2014 [13]; bInjuries include minor and major injuri
24–30) and mild/severe cognitive decline (score 0 – 23); dNutrition: dichotomized in
malnutrition/malnourished (score 0–11).living situation, fall history, CCI, MOB-T for fatigue,
polypharmacy, VAS for pain, MMSE, GDS and MNA-SF.
Multivariate logistic regression was performed on the
patients with fully completed baseline variables. To
perform this multivariate logistic regression, a multiple
variable logistic model was used. Variables achieving a
significance level of 0.05 in univariate analyses were
entered in the multivariate analysis with stepwise vari-
able selection and p-values to enter and to stay in the
model of 0.05. Multiple collinearity was investigated
with variance inflation factor (VIF).
Results
Patient characteristics
To participate in the study 1056 patients were approached.
Written informed consent was given by 931 patients and
six caregivers, resulting in 937 patients included. At timen % 95%CI
ce of a geriatric risk profile : score 0 164 17.5 15.1-19.9
ce of a geriatric risk profile : ≤ 1 773 82.5 80.1-84.9
ce of a geriatric risk profile : score > 14 240 25.6 22.8-28.4
ce of a geriatric risk profile : score≤ 14 697 74.4 71.6-77.2
n % 95%CI
alone 283 30.2 27.3-33.1
ving alone 654 69.8 66.9-72.7
endent: score 6 455 48.6 45.4-51.8
dent: score≥ 7 482 51.4 48.2-54.6
endent: score 8 (female) or 5 (male) 399 42.6 39.4-45.7
dent: score < 8 (female) or 5 (male) 538 57.4 54.2-60.6
lls 642 68.5 65.5-71.5
without injury 41 4.4 3.1-5.7
with injury 114 12.2 10.1-14.3
ls without injury 35 3.7 2.5-4.9
ls with injury 105 11.2 9.2-13.2
tigue 369 39.4 36.3-42.5
ce of fatigue 568 60.6 57.5-63.7
al cognition: score≥ 24 837 89.4 87.5-91.4
ognitive decline: score 18–23 84 9.0 7.1-10.8
cognitive decline: score≤ 17 15 1.6 0.8-2.4
t risk for depression: score 0–4 741 79.4 76.8-82.0
for depression: score 5–15 192 20.6 18.0-23.2
al nutritional status: score≥ 12 340 36.3 33.2-39.4
f malnutrition: score 8–11 422 45.0 41.9-48.2
urished: score≤ 7 175 18.7 16.2-21.2
ssment; ADL: Activities of Daily Living; IADL: Instrumental Activities of Daily
S: Geriatric Depression Scale; MNA-SF: Mini Nutritional Assessment-Short Form.
es; cCognition: dichotomized in logistic regression in normal cognition (score
logistic regression in normal nutritional status (score 12–14) and risk of
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of 2.38 months), fall-related data of 809 patients were
available (see Figure 1).
Patient and clinical characteristics are listed in Table 1.
The majority was female (595; 63.5%) and the median
age was 76 years old (range 70–95). The most common
malignancy was breast cancer (40.4%), followed by colo-
rectal cancer (20.6%) and hematological malignancies
(15.9%). Most participants (61.0%) had a new cancer
diagnosis at inclusion and nearly half (46.1%) of patients
had no comorbidities. Congestive heart failure (18.4%)
and diabetes mellitus without complications (13.4%) were
the most common comorbidities.
Based on geriatric screening with G8 and fTRST, 697
(74.4%) and 773 (82.5%) patients had an abnormal screen-
ing result, respectively. Further results of the GA are
described in Table 2. Abnormal nutritional status (63.7%)
and presence of fatigue (60.6%) were the most frequent
deficiencies. Both ADL (51.4%) and IADL (57.4%) instru-
ments found functional dependence for half of the in-
cluded patients. Nearly one third was living alone (30.2%).
Occurrence of falls and fall related injuries at baseline
and at follow-up
At baseline, 295 (31.5%) patients reported at least one
fall in the past 12 months of which 219 patients (74.2%)
sustained an injury. A major injury was reported by 88
patients (29.8% of fallers or 40.2% of fallers with injury).
At follow-up, a fall was reported by 142 patients
(17.6%), of whom 51.4% fell more than once. Injurious
falls and those resulting in major injuries were reported
in 88 (62.0%) and 25 patients (17.6% of fallers),Figure 2 Occurrence of falls at baseline and follow-up.respectively. One out of every four falls with an injury
was major (28.4%) (Figure 2).
Fall risk during follow-up was significantly higher in
patients with baseline fall history in the past 12 months
compared to those without fall history (35.4% versus
9.9%; p < 0.0001). For severity of injury, no difference was
found for patients with or without baseline fall history in
the past 12 months (p = 0.78).
Univariate predictors for falls (≥1 fall)
Comparison of non-fallers with fallers (≥1 fall), single
fallers (=1 fall) and recurrent fallers (≥2 falls) was possible
for the following variables: age, fTRST, G8, ADL, IADL,
living situation, fall history in the past 12 months, CCI,
MOB-T for fatigue, polypharmacy, VAS for pain, MNA-SF
and ECOG-PS. Low functionality (e.g. dependent on ADL
or IADL), living alone, reported fall history in the past
12 months, geriatric risk profile (e.g. higher score on
fTRST or lower score on G8), nutritional problems, high
ECOG-PS, fatigue, polypharmacy and mild pain/pain to
treat were all significantly associated with falling, one
single fall only and recurrent falls during follow-up.
Cognitive decline and risk for depression were both
significantly related to falling during follow-up. The latter
was also significantly associated with recurrent falls
(Table 3).
Multivariate predictors for falls (≥1 fall) during follow-up
Multivariate logistic regression was performed on the
patients with fully completed baseline variables (n = 781).
This regression analysis showed that falling (≥1 fall),
within 2 to 3 months after cancer treatment decision








(1 fall) (n = 69)*
Recurrent fallers







Age 70-74 322 (39.8%) 278 (41.7%) 44 (31.0%) 23 (33.3%) 21 (28.8%) 0.0511 0.0955 0.1703
75-79 256 (31.6%) 207 (31.0%) 49 (34.5%) 20 (29.0%) 29 (39.7%)
≥80 231 (28.6%) 182 (27.3%) 49 (34.5%) 26 (37.7%) 23 (31.5%)
Gender Female 528 (65.3%) 435 (65.2%) 93 (65.5%) 45 (65.2%) 48 (65.8%) 0.95 1.0 0.93
Male 281 (34.7%) 232 (34.8%) 49 (34.5%) 24 (34.8%) 25 (34.3%)
G8 No geriatric risk profile
(>14)
232 (28.7%) 218 (32.7%) 14 (9.9%) 6 (8.7%) 8 (11.0%) <0.0001 <0.0001 0.0001
Geriatric risk profile (≤14) 577 (71.3%) 449 (67.3%) 128 (90.1%) 63 (91.3%) 65 (89.0%)
fTRST No geriatric risk profile (0) 153 (18.9%) 147 (22.0%) 6 (4.2%) 2 (2.9%) 4 (5.5%) <0.0001 0.0002 0.0009
Geriatric risk profile (≥1) 656 (81.1%) 520 (78.0%) 136 (95.8%) 67 (97.1%) 69 (94.5%)
ADL Independent (6) 413 (51.1%) 375 (56.2%) 38 (26.8%) 16 (23.2%) 22 (30.1%) <0.0001 <0.0001 <0.0001
Dependent (≥7) 396 (48.9%) 292 (43.8%) 104 (73.2%) 53 (76.8%) 51 (69.9%)
IADL Independent (5(male)/8
(female)
367 (45.4%) 325 (48.7%) 42 (29.6%) 18 (26.1%) 24 (32.9%) <0.0001 0.0003 0.01
Dependent (≤4(male)/≤7
(female))
442 (54.6%) 342 (51.3%) 100 (70.4%) 51 (73.9%) 49 (67.1%)
Living situation Not living alone 571 (70.6%) 486 (72.9%) 85 (59.9%) 42 (60.9%) 43 (58.9%) 0.002 0.0352 0.01
Living alone 238 (29.4%) 181 (27.1%) 57 (40.1%) 27 (39.1%) 30 (41.1%)
Fall history in the
past 12 months
No falls 566 (70.0%) 510 (76.5%) 56 (39.4%) 32 (46.4%) 24 (32.9%) <0.0001 <0.0001 <0.0001
Falls (≥1) 243 (30.0%) 157 (23.5%) 86 (60.6%) 37 (53.6%) 49 (67.1%)
CCI No comorbidities (0) 388 (48.0%) 326 (48.9%) 62 (43.7%) 27 (39.1%) 35 (47.9%) 0.26 0.1230 0.88
Comorbidities (≥1) 421 (52.0%) 341 (51.1%) 80 (56.3%) 42 (60.9%) 38 (52.1%)
MOB-T for
fatigue
No fatigue 339 (41.9%) 313 (46.9%) 26 (18.3%) 12 (17.4%) 14 (19.2%) <0.0001 <0.0001 <0.0001
Fatigue 470 (58.1%) 354 (53.1%) 116 (81.7%) 57 (82.6%) 59 (80.8%)
Poly-pharmacy Absence (0–4 drugs) 386/785 (49.2%) 338/649 (52.1%) 48/136 (35.3%) 22/66 (33.3%) 26/70 (37.1%) 0.0004 0.0037 0.02
Presence (≥5 drugs) 399/785 (50.8%) 311/649 (47.9%) 88/136 (64.7%) 44/66 (66.7%) 44/70 (62.9%)
VAS for pain No pain (0) 408 (50.4%) 359 (53.8%) 49 (34.5%) 23 (33.3%) 26 (35.6%) <0.0001 0.0012 0.003
Mild pain/pain to treat
(1–10)
401 (49.6%) 308 (46.2%) 93 (65.5%) 46 (66.7%) 47 (64.4%)
MMSE Normal cognition (≥24) 738 (91.2%) 615 (92.2%) 123 (86.6%) 59 (85.5%) 64 (87.7%) 0.03 0.0566 0.18
Mild/severe cognitive
decline (≤23)
71 (8.8%) 52 (7.8%) 19 (13.4%) 10 (14.5%) 9 (12.3%)
GDS Not at risk for depression
(0–4)




















Table 3 Univariate predictors of occurrence of falls during follow-up (Continued)
At risk for depression
(≥5)
143/806 (17.7%) 106/665 (15.9%) 37/141 (26.2%) 16/68 (23.5%) 21 (28.8%)
MNA-SF Normal nutritional status
(≥12)
412 (50.9%) 367 (55.0%) 45 (31.7%) 21 (30.4%) 24 (32.9%) <0.0001 <0.0001 0.0003
Risk of malnutrition/
malnourished (≤11)
397 (49.1%) 300 (45.0%) 97 (68.3%) 48 (69.6%) 49 (67.1%)
ECOG PS Score 0-1 619/808 (76.6%) 529/666 (79.4%) 90 (63.4%) 42 (60.9%) 48 (65.8%) <0.0001 0.0004 0.0073
Score 2-4 189/808 (23.4%) 137/666 (20.6%) 52 (36.6%) 27 (39.1%) 25 (34.3%)
Legend: fTRST: Flemish version of Triage Risk Screening Tool; ADL : Activities of Daily Living; IADL : Instrumental Activities of Daily Living; CCI: Charlson Comorbidity Index; MOB-T : Mobility-Tiredness test; VAS: Visual
Analogue Scale; MMSE: Mini Mental State Examination; GDS: Geriatric Depression Scale; MNA-SF: Mini Nutritional Assessment - Short Form. ECOG PS: Eastern Cooperative Oncology Group - Performance Status.




















Figure 3 Multivariate predictors for occurrence of falls (≥1 fall) during follow-up.
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fatigue, ADL dependency, geriatric risk profile by G8
and living situation (Figure 3, Table 4). There was no
collinearity between the independent variables.
Discussion
This study examined incidence and risk factors for falls
within two to three months after a cancer treatment deci-
sion in older cancer patients. Independent fall predictors
were fatigue, living alone, ADL dependency, geriatric risk
profile by G8 and fall history in the past 12 months.
At baseline, one in every 3 patients reported a fall in
the past 12 months, which is comparable with fall inci-
dence in community-dwelling older adults [1,2]. However,
falls in older cancer patients might be underreported. Dur-
ing follow-up, 17.6% of patients had experienced already a
fall, which is remarkable given the short follow-up. The
current study did not find a higher fall rate for patients
with advanced cancer, as reported by Stone (one in everyTable 4 Multivariate predictors of occurrence of falls (≥1 fall)
Coefficients
−1.846
Selected baseline variables Coefficients
Fall history in the past 12 months (fall history vs no
fall history in the past 12 months)
0.684
ADL (ADL independent vs ADL dependent) −0.354
MOB-T for fatigue (no fatigue vs fatigue) −0.484
Geriatric risk profile by G8 (no geriatric risk profile vs
geriatric risk profile)
−0.377
Living situation (living alone vs not living alone) 0.245
Legend: ADL: Activities of Daily Living; MOB-T: Mobility Tiredness Test.two patients) [11]. Maybe, less frail patients with advanced
cancer were included, since these were able to visit the
hospital. Of note, recurrent fall rate (51.4% within follow-
up) and the number of falls with major injury (29.8% of
fallers at baseline; 17.6% of fallers within follow-up) were
both high in comparison to international research findings
among community-dwelling older adults (38.1-53.8% and
10-15%), confirming earlier findings and underlining the
urgent need for effective preventive measures [1,2,31].
Multivariate analysis identified several independent fall
predictors among older cancer patients. In accordance
with other studies, fall history was the main predictor
for a future fall [6,7]. Patients with a fall history in the
past 12 months at baseline were almost 4 times more
likely to fall shortly after cancer treatment decision
compared to patients without a fall history in the past
12 months at baseline. Another risk factor was geriat-
ric risk profile by G8. This might be explained by the
association between (history of ) a fall and frailty induring follow-up (n = 781)
Wald Chi Square p-value
130.4 <0.0001
Wald Chi-Square p Odds ratio’s 95% CI
43.3 <0.0001 3.926 2.612-5.901
9.5 0.002 0.492 0.314-0.772
13.7 0.0002 0.380 0.228-0.634
5.5 0.019 0.471 0.251-0.883
5.2 0.023 1.631 1.071-2.482
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a correlation between frailty markers and falls in older
cancer patients [10]. Other predictors were functional
capacity and fatigue, which might be inversely related.
Patients with decreased functional capacity spend
more effort relative to maximal ability to perform usual
activities, leading to higher levels of fatigue [33]. Whereas
the association between functional dependency and falls is
well known [34,35], the relation between falls and cancer/
treatment-related fatigue is not well documented. How-
ever, physical fatigue may represent a risk factor for falls
in older persons, since gait changes following a strenuous
task are comparable to gait changes found in older per-
sons with falls [36]. Although the effect of physical activity
on cancer-related fatigue is controversial [37,38], clinicians
should promote it, since physical activity might be benefi-
cial to maintain/improve functional capacity. The last
predictor was living alone, indicating that social support
in daily life after a cancer treatment decision is not only
necessary for emotional health, but also for mobility
issues. This is in opposition with the presumption that
patients living alone are more independent and have a
lower risk of falling. The identification of these fall predic-
tors allow for targeted preventive measures based on geriat-
ric screening and assessment data. Indeed, good prevention
starts with improvement of modifiable risk factors.
Other predictors for falls in older adults, such as decreased
cognition, depression, malnutrition and polypharmacy, were
not identified among older cancer patients in the current
study. However, there was some evidence of an effect of each
that may have been too marginal to allow for inclusion into
a multivariate analysis. Of course, this finding does not ques-
tion the clinical relevance of these variables. As stated in the
introduction, a fall is often caused by several, interacting
factors. So, preventive measures in patients with high fall risk
according to the identified fall predictors should be tailored
considering all factors possibly contributing to higher odds
of falling. According to fall risk assessment and the imple-
mentation of preventive measures, several guidelines have
been developed of which the guidelines of the American
Geriatrics Society ‘Prevention of falls in older persons’ [39]
and the NICE guideline ‘Falls: assessment and prevention of
falls in older people’ [40] are recommended.
This study has some limitations. Several risk factors for
falls (e.g. vision, orthostatic hypotension, use of fall risk-
increasing medication classes) were not explored. However,
limiting study data to those available at the moment of
treatment decision might be more relevant for clinical
practice. Another limitation is the short follow-up period,
possibly leading to overestimation of fall events. In addition,
falls and fall history may have been underreported due to
recall bias, although similarity between reported 12 month
fall history at baseline and fall incidence in community-
dwelling older adults supports the assumption that ourdata are reasonably valid and reliable. Still, future research
should consider the use of a fall calendar. Furthermore,
most of the included patients had a good cognition and a
low number of comorbidities, suggesting that the studied
sample might have been a selection of a less frail older
cancer population. Strengths of this study are the pro-
spective design, the large and heterogeneous sample,
and the acceptable drop-out rate considering the popu-
lation of interest.
Conclusion
In conclusion, falls are a serious and underestimated prob-
lem among older cancer patients. Fatigue, living alone,
ADL dependency, geriatric risk profile by G8 and fall
history (in the past 12 months) were independent predic-
tors of a fall. This study demonstrates that geriatric screen-
ing and assessment are useful for identifying older cancer
patients at risk for falls. This allows for individually tailored
interventions that might improve outcomes in this particu-
larly vulnerable population.
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